Evidence map›Paper›PMID 36684115›Full record

ReviewSaudi journal of biological sciences2023

A comprehensive perspective of traditional Arabic or Islamic medicinal plants as an adjuvant therapy against COVID-19.

Shabina Ishtiaq Ahmed, Sehrish Jamil, Humaira Ismatullah, Rashid Hussain, Shabana Bibi, Mayeen Uddin Khandaker, Aisha Naveed, Abubakr M Idris, Talha Bin Emran

Open access · hybridAbstract readReview
In one paragraph

Review in Saudi journal of biological sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 6 countries.

Shabina Ishtiaq AhmedDepartment of Plant Biotechnology, Atta-Ur-Rahman School of Applied Biosciences (ASAB), National University of Sciences and Technology (NUST), 44000, Islamabad, Pakistan.
Sehrish JamilThe Standard College for Girls, 3/530 Paris Road, Sialkot Pakistan.
Humaira IsmatullahSchool of Interdisciplinary Engineering & Sciences (SINES), National University of Sciences and Technology (NUST), 44000 Islamabad, Pakistan.
Rashid HussainDepartment of Biosciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
Shabana BibiDepartment of Biosciences, Shifa Tameer-e-Millat University, Islamabad, Pakistan.
Mayeen Uddin KhandakerCenter for Applied Physics and Radiation Technologies, School of Engineering and Technology, Sunway University, Bandar Sunway 47500, Selangor, Malaysia.
Aisha NaveedCaribbean Medical University, Willemastad, Curacao-Caribbean Island, Curaçao.
Abubakr M IdrisDepartment of Chemistry, College of Science, King Khalid University, Abha 62529, Saudi Arabia.
Talha Bin EmranDepartment of Pharmacy, BGC Trust University Bangladesh, Chittagong 4381, Bangladesh.
Pakistan Army · PKShifa Tameer-e-Millat University · PKBGC Trust University Bangladesh · BDCaribbean Research and Management of Biodiversity Foundation · CWKing Khalid University · SANational University of Sciences and Technology · PKSunway University · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is a pulmonary disease caused by SARS-CoV-2. More than 200 million individuals are infected by this globally. Pyrexia, coughing, shortness of breath, headaches, diarrhoea, sore throats, and body aches are among the typical symptoms of COVID-19. The virus enters into the host body by interacting with the ACE2 receptor. Despite many SARS-CoV-2 vaccines manufactured by distinct strategies but any evidence-based particular medication to combat COVID-19 is not available yet. However, further research is required to determine the safety and effectiveness profile of the present therapeutic approaches. In this study, we provide a summary of Traditional Arabic or Islamic medicinal (TAIM) plants' historical use and their present role as adjuvant therapy for COVID-19. Herein, six medicinal plants

Indexed as

ACE2Adjuvant therapyAleo veraAntiviralCOVID-19PhytochemicalsSARS-CoV-2Traditional Arabic or Islamic medicinal plants

Identifiers

PMID36684115
PMCPMC9838045
OpenAlexW4316035291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.